Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | MGLL | Q99685 | 3/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | CDC25A | P30304 | 10/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.39 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15720674 | 1.00 | PTGS1 (0.44) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL20434465 | 1.00 | PTGS1 (0.44) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL13859021 | 0.94 | ALDH1A1 (0.37) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL20434472 | 0.84 | PTGS1 (0.45) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL20434454 | 0.84 | PTGS1 (0.45) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL20434466 | 0.84 | PTGS1 (0.45) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL15720775 | 0.83 | CDC25A (0.39) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL15739410 | 0.82 | CDC25A (0.38) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL15730468 | 0.81 | PTGS1 (0.42) | PTGS1PTGS2MGLLFAAHCDC25A | |
| SCHEMBL20434458 | 0.79 | PTGS1 (0.41) | PTGS1PTGS2MGLLFAAHCDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180219160-A1 | BENZOBIS(THIADIAZOLE) DERIVATIVE, INK COMPRISING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME | IKZF3, HELZ, TEC | PTGS1 2391/4885PTGS2 2445/4885MGLL 4773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.